Buy Ranbaxy on every dip: Sukhani

Buy Ranbaxy on every dip, says Sudarshan Sukhani of s2analytics.com.

Sukhani told CNBC-TV18, "Ranbaxy Laboratories is an excellent chart, a long-term target is Rs 700 plus but even now currently it's just on the verge of moving above that Rs 530-535 resistance and Rs 555-560 is the target for the immediate term. It is a stock we want to buy on every dip and consolidation."

He further added, "In Voltas we have seen an up day then down day that was a correction. Now that the correction has held and it hasn’t actually broken the lows that it could have, so that is good news. So maybe it will go in a trading range but the bias now should be to go long in it. At current levels I think there is another 5-6% or even an 8% rally possible. So Rs 110 target is for Voltas and it’s a long."